From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies successfully identified a matched unrelated donor (MUD) through the Italian Bone Marrow Donor Registry (IBMDR), corresponding to a transplant efficiency of 62%
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantati...
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantati...
Between January 1989 and July 1995 the search for an unrelated donor (UD) was started for 379 consec...
From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies successfully id...
BACKGROUND From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies suc...
BACKGROUND AND OBJECTIVES. Unrelated donor bone marrow transplant (UD-BMT) has become an attractive ...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
BACKGROUND AND OBJECTIVES: Unrelated donor bone marrow transplant (UD-BMT) has become an attractive,...
From 1 September 1988 to 30 September 1993, a search for an unrelated donor (URD) was started for 63...
From 1 September 1988 to 30 September 1993, a search for an unrelated donor (URD) was started for 63...
BACKGROUND AND OBJECTIVES: Allogeneic bone marrow transplantation (BMT) is a widely accepted therape...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
The information regarding the probability of finding a matched unrelated donor (MUD) within a relati...
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantati...
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantati...
Between January 1989 and July 1995 the search for an unrelated donor (UD) was started for 379 consec...
From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies successfully id...
BACKGROUND From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies suc...
BACKGROUND AND OBJECTIVES. Unrelated donor bone marrow transplant (UD-BMT) has become an attractive ...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
BACKGROUND AND OBJECTIVES: Unrelated donor bone marrow transplant (UD-BMT) has become an attractive,...
From 1 September 1988 to 30 September 1993, a search for an unrelated donor (URD) was started for 63...
From 1 September 1988 to 30 September 1993, a search for an unrelated donor (URD) was started for 63...
BACKGROUND AND OBJECTIVES: Allogeneic bone marrow transplantation (BMT) is a widely accepted therape...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
The information regarding the probability of finding a matched unrelated donor (MUD) within a relati...
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantati...
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantati...
Between January 1989 and July 1995 the search for an unrelated donor (UD) was started for 379 consec...